Medical Depot, Inc. dba Drive DeVilbiss Healthcare.
Invacare Corporation
±âŸ
AJY
¿µ¹® ¸ñÂ÷
¿µ¹®¸ñÂ÷
U.S. Continuous Positive Airway Pressure Devices Market Growth & Trends:
The U.S. continuous positive airway pressure devices market is anticipated to reach USD 820.85 million by 2030, registering a CAGR of 4.44% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by several factors, including the increasing prevalence of sleep apnea and respiratory conditions, advancements in CPAP device technology, increased awareness and diagnosis of sleep apnea, and supportive reimbursement policies.
Technological advancements represent another crucial driver in the U.S. CPAP market. Continuous innovation has led to the development of more user-friendly, quieter, and compact devices, enhancing patient comfort and compliance. Introducing innovative technologies, such as remote monitoring and connectivity features, allows patients to track their sleep patterns and treatment progress, driving an active role in their healthcare.
Increased awareness campaigns by healthcare organizations and government bodies lead to more individuals seeking diagnosis and treatment for sleep apnea. In addition, favorable reimbursement policies by insurance providers make CPAP therapy more accessible to a broader population segment. Recognizing the long-term benefits of CPAP therapy in preventing complications associated with untreated sleep apnea also encourages healthcare providers to recommend and prescribe these devices frequently.
U.S. Continuous Positive Airway Pressure Devices Market Report Highlights:
On the basis of connectivity, the connected segment held the largest market share of 68.83% in 2024 and is anticipated to grow at the fastest CAGR for the forecast period. The growth of this segment is driven by advancements in sleep apnea management, including improved technology integration for real-time monitoring and tailored care, which enhances user adherence and treatment effectiveness.
On the basis of end use, the home care settings segment held the largest market share in 2024 and is anticipated to grow at the fastest CAGR for the forecast period. The expansion of this segment is driven by the increasing prevalence of obstructive sleep apnea (OSA) and advancements in CPAP technology, which are increasing the adoption of homecare CPAP therapy as an affordable, comfortable, and convenient solution for patients.
Some prominent players in the U.S. CPAP devices market include ResMed, Koninklijke Philips N.V., Fisher & Paykel Healthcare Limited, and Medical Depot, Inc. dba Drive DeVilbiss Healthcare.
In November 2024, Fisher & Paykel Healthcare introduced the F&P Nova Micro nasal pillow mask in the U.S., marking the company's smallest and lightest CPAP therapy mask so far.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment Definitions
1.2. Estimates and Forecast Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR's Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.4.5. Details of Primary Research
1.4.6. Research Assumption
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Data Visualization
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. Objectives
1.8.1. Objective - 1
1.8.2. Objective - 2
1.8.3. Objective - 3
1.9. List of Secondary Sources
1.10. List of Secondary Sources
Chapter 2. Executive Summary
2.1. U.S. CPAP Devices Market
2.1.1. Market Snapshot
2.1.2. Segment Snapshot
2.1.2.1. Connectivity segment outlook
2.1.2.2. End Use segment outlook
2.1.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Rising incidence of obstructive sleep apnea (OSA)
3.3.1.2. Technological advancements
3.3.1.3. Supportive initiatives by government and private organizations for CPAP devices
3.3.2. Market Restraint Analysis
3.3.2.1. Product recalls & failure
3.3.2.2. Complex regulatory framework pertaining to CPAP devices
3.3.3. Market Opportunity Analysis
3.3.3.1. Growing adoption of CPAP devices in home care settings
3.3.4. Market Challenges Analysis
3.3.4.1. Regulatory and reimbursement challenges
3.4. U.S. CPAP Devices Market Analysis Tools: PESTEL